Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ADP-ribosylation factor-like protein 8A (ARL8A) is a member of the Ras small GTPase superfamily, primarily localized to lysosomal membranes, with a central role in regulating lysosome positioning and anterograde transport through the recruitment of specific adaptor proteins to kinesin motors. Its function is pivotal for processes such as antigen presentation, cytotoxic activity of natural killer cells, extracellular matrix degradation, and cancer cell invasion, as well as synaptic assembly and autophagy. Emerging studies also identify ARL8A as a clinical biomarker in certain cancers, and its associated gene (ARL8A) displays genetic links to Bardet-Biedl syndrome. While core interacting drugs or direct safety concerns are not established, its fundamental importance for lysosome-dependent cellular functions makes it a focus in cellular and disease research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ADP-ribosylation factor-like protein 8A (ARL8A).